Logo
 Home | Sitemap | Contact us | Search | Language
Left Right
Home >> Industrial and Microbial Biotechnology >> Protein and Enzymes Engineering >> De Novo Design of Catalysts

De novo Design of Catalysts
Sometimes existing enzymes provide no solutions for the intended reactions. In such cases molecules evolved for purposes other than catalysis may be engineered to function as enzymes. Antibodies or enzymes provide one such example, although they have low expression, limited stability and low turnover rates, thus making their commercial exploitation difficult. These enzymes, however, were generated in response to molecules that mimic the transition state of a reaction. Molecules other than antibodies can also be used for this purpose.

Peptide biocatalysts (de novo designed) failed as enzymes.
Natural biocatalysts of enzymes sometimes pose serious problems, Sometimes, enzymes are too unwieldy, or the because, either the biological pathways are too combersome. Alternatives, therefore, have been sought and following types of novel biocatalysts have been generated and tried: (i) enzymes (catalytic antibodies); (ii) re-engineered enzymes (RNES); (iii) ribozymes (catalytic RNA); (iv) de novo design (peptides, etc.).
Among these, the first three approaches have shown some promise, although so far none of these could be put to industrial use. However, two efforts for the synthesis of peptides (CHZ-1, Chz Pepz and TrPepz) to be used as chymotrypsin and trypsin, reported in early 1990s, could not be repeated later.
Therefore, the initial hope of the future of peptides as enzymes was not fulfilifed, and the small peptides representing mere catalytic sites, no longer provide an exciting alternative for biocatalysts. Only in future, we will know if enzymes and ribozymes, could be suitable alternatives, although RNAs certainly have a promise.

 

Left Right